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Abstract
Background: Supraventricular arrhythmia (SVA) is a frequent clinical complication in
adult patients with congenital heart disease (CHD). The aim of this study is prognostic
evaluation of congenital heart defect complexity, performed cardiac surgery, initial functional
impairment of the heart — NYHA > I, cyanosis, age and sex of the adult patients with CHD,
presenting for the first time to an outpatient clinic, on SVA occurrence during long-term
observation.
Methods: We looked at 1,304 patients (586 men), aged 18–72 years (mean 29.4 ± 10.6
years), and followed-up from 1995 to 2004. The mean observation period was 3.52 ± 1.83
years. SVA in the form of atrial flutter/fibrillation (FA/FLA) and supraventricular tachycar-
dia was observed in 133 patients, 10.3% of the study population. Ten-year follow-up showed
that the likelihood of SVA occurrence in the whole studied population after two years was
5.2%, and 14.4% after ten years.
Results: Univariate analysis proved that the incidence of SVA is greater in patients with
complex heart defects (p = 0.0001), those not previously operated upon (p = 0.0001), those
with baseline impairment of cardiac function (NYHA > I; p = 0.0001) and those with
cyanosis (0.0001). The patient’s sex seems to have little significance. Cox regression analysis
showed that baseline heart failure is the strongest risk factor for SVA (HR = 4.66). Congenital
heart defect complexity (HR = 2.31) and the patient’s age are also significant prognostic
factors of this arrhythmia (HR = 1.32). Cardiac surgery, cyanosis and patient sex are not
significant in prognosis.
Conclusions: Baseline impairment of heart function, heart defect complexity and patient’s
age all increase the risk of SVA in the population of adults with congenital heart disease.
Cyanosis and the lack of cardiac surgery in the past led to a higher incidence of the analyzed
arrhythmia but are not risk factors for its occurrence. Gender has no prognostic significance
for SVA. (Cardiol J 2009; 16, 3: 218–226)
Key words: adult patients with congenital heart disease, supraventricular
arrhythmia
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Introduction
Supraventricular arrhythmias (SVA) are a fre-
quent clinical complication seen in adult patients
with congenital heart disease (CHD). They often
lead to hospitalization, serious deterioration of
heart function and death [1, 2]. The pathogenesis
of this arrhythmia in adults is complex and it stems
from: a) primary anomalies in the conduction path-
ways, b) atrial enlargement, followed by its dilation/
/distension, fibrosis and increased wall tension
leading to inhomogeneity of electric stimulation,
c) presence of postoperative scarring, aiding in slowed
impulse transduction ‘incisional reentry’, d) deterio-
ration of ventricular function: SVA result from
hemodynamic dysfunction but can at the same time
lead to progression of dysfunction, e) impairment of
sinus function, facilitating recurrent arrhythmia [3–9].
As a result, optimal management of complex
patients should involve the specialist cardiologist
in adults with congenital heart disease, as well as
an electrophysiologist or surgeon with a particular
interest and experience in this area. Rational tre-
atment of this scarce but constantly growing popu-
lation of patients requires sound knowledge of risk
factors related to the discussed arrhythmia. The
presented pathomechanisms of SVA indicate that
its occurrence is influenced by anatomical comple-
xity of the defect, past cardiac surgery and initial
impairment of cardiac function. Blood desaturation
and the age of the patient seem to play some role
as well. The available studies usually relate to pa-
tients affected by particular defects [3–6, 10, 11].
There are no risk factor analyses available for SVA
in the long-term observation of the adult population
with congenital heart disease carried out by
a single specialized clinical facility.
This study aims at the prognostic evaluation of
selected parameters defining adult patients with
CHD who presented to an outpatient clinic for the
first time, in the context of SVA incidence in long-
term follow-up. The considered variables included:
congenital heart disease complexity, previous car-
diac surgery, initial impairment of cardiac function
— NYHA class > I, presence of cyanosis, patients’
age and sex.
Methods
We looked at 1,304 patients with CHD (718 wo-
men and 586 men), aged 18 to 72 years (mean 29.1 ±
± 0.6 years), who were treated in the Adult Con-
genital Outpatient Clinic at the Poznan Medical
University between 1995 and 2004. Simple
defects occurred in 886 patients (which amounted
to 67.9% of the studied population) 418 patients
presented with complex defects (32.1%) and
962 (73.7%) patients were operated on at the mean
age of 9.8 ± 8.5 years; 78 (5.9%) patients were
cyanotic and 108 (8.4%) presented with baseline
impairment of cardiac function (NYHA > I).
Baseline clinical analysis
A detailed medical history was taken, including
the type and frequency of past cardiac surgery,
a thorough physical examination, electrocardiogra-
phy and echocardiography which allowed for verifi-
cation of, or arriving at, a clinical diagnosis. Hemo-
dynamic assessment was performed only in cases
of inconclusive diagnostic results, in order to eva-
luate pulmonary pressure and resistance of pulmo-
nary arteries as well as anomalies of the coronary
arteries. If patients presented with more than one
cardiovascular anomaly, they were put into groups
according to the hemodynamically dominant defect.
Based on a classification approved by Jane Some-
rville, the chairman of experts of the British Car-
diac Society Working Party [1], the population of
patients was divided into a group of patients with
simple, and another group with complex, congeni-
tal heart anomalies.
Table 1 presents numbers of patients with par-
ticular simple and complex congenital heart defects,
demographic data, cardiac surgery data, cyanosis and
initial impairment of heart function (NYHA > I).
Follow-up clinical analysis
Patients were observed for between one and
ten years (mean 3.52 ± 1.83 years). Heart function
was presented according to New York Heart Asso-
ciation (NYHA) functional classification. A minimum
of class II NYHA was assumed as baseline cardiac
functional impairment. Cyanosis was defined as pink
coloration of the skin and mucous membranes with
oxygen saturation not exceeding 85%, with exclu-
sion of its extracardiac causes. Arrhythmias were
recognized when diagnosed with electrocardiogra-
phy during outpatient clinic observation, local
hospital or general practitioner visits or using Holter
monitoring (459 24-hour ECGs were performed).
Serious SVA included supraventricular tachycardia
(SVT) defined as at least five QRS complexes at
a rate of > 100 beats/min [7] and atrial flutter/
/fibrillation (AF/FLA), diagnosed according to
generally recognized criteria.
The study was approved by the bioethical
committee and all patients gave their informed
consent.
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Statistical analysis
Continuous variables were presented as mean
(standard deviation). Comparisons between the two
groups were conducted using Student’s test for
normally distributed continuous variables or Mann-
Whitney test for those without normal distribution.
c2 or Fisher’s exact test was used for categorical
variables. Kaplan-Meier curves were plotted to
describe the cumulative probability of arrhythmia-
free survival. The long-rank test was used to com-
pare curves according to the patient’s sex, congeni-
tal heart disease complexity, presence of cyanosis,
baseline impairment of cardiac function (NYHA > I)
and by past cardiac surgeries. The aforementioned
variables and the patient’s age that were thought
to have a possible impact on occurrence of SVA in
these patients were included in a multivariate Cox
analysis. The results were reported as hazard ratios
(HR) and 95% confidence intervals (CI). The stati-
stical significance was assigned at a p value £ 0.05.
Results
Supraventricular arrhythmias, atrial flutter/
/fibrillation and supraventricular tachycardia were
observed in 133 patients, 10.3% of the studied
Table 1. Characteristics of study population of adults with congenital heart disease (CHD). Demogra-
phic data, past cardiac surgery, presence of cyanosis and initial decrease of heart function (NYHA > I)
at the baseline outpatient clinic visit.
N Males Age Number Age at Number Number
(%) (years) of operated surgery of cyanotic of patients
patients (%)  (years) patients (%) with baseline
NYHA > I
Simple CHD
ASD* 278 102 (36.6%) 32.6±12.9 200 (71.9%) 12.1±9.7 0 3 (1.08%)
VSD* 277 135 (48.7%) 27.6±9.3 226 (81.5%) 8.4±8.0 0 3 (1.08%)
PDA* 120 29 (24.1%) 27.5±9.5 116 (96.6%) 7.2±6.1 0 0
BAV 107 71 (66.3%) 26.9±6.7 36 (33.6%) 15.4±7.1 0 1 (0.93%)
PS 70 30 (42.8%) 27.5±9.1 49 (70%) 9.2±6.6 3 (4.3%) 3 (4.3%)
PPVC 10 5 (50%) 31.2±14.5 10 (100%) 14.7±12.6 0 2 (20.0%)
Marfan 9 3 (33.3%) 26.8±9.8 1 (11.1%) 20.0 0 0
IPD 8 2 (25.0%) 32.0±11.8 0 0 0 0
MI 6 1 (16.6%) 24.7±3.8 2 (33.3%) 17.0±1.4 0 0
Wiliams 1 0 24.0 0 0 0 0
Total 886 378 (42.6%) 29.1±10.6 640 (72.2%) 9.9±8.5 3 (0.34%) 12 (1.35%)
Complex CHD
CoAo 106 61 (57.5%) 29.9±9.5 103 (97.2%) 10.2±7.0 0 7 (6.6%)
ToF 101 51 (50.5%) 27.8±7.7 96 (95.0%) 7.4±5.2 7 (6.9%) 9 (8.9%)
ASD I 38 17 (44.7%) 28.2±9.9 38 (100%) 11.8±10.8 0 3 (7.9%)
CAVC 32 12 (37.5%) 27.6±8.3 18 (56.2%) 5.7±3.0 8 (25.0%) 8 (25.0%)
Eisenmenger 27 6 (22.2%) 45.5±14.3 0 0 27 (100%) 27 (100%)
SubvalvAS 24 14 (58.3%) 30.0±10.3 15 (62.5%) 15.9±13.0 0 0
Single ventricle 23 11 (48.7%) 26.7±7.9 16 (69.6%) 8.9±4.2 20 (87.0%) 20 (87.0%)
Ebstein 20 15 (75%) 41.2±11.2 0 0 4 (20.0%) 9 (45.0%)
DTGA 19 9 (47.4%) 24.7±4.8 16 (84.2%) 3.5±3.2 7 (36.8%) 1 (11.1%)
Valve conduits 9 5 (55.6%) 26.9±7.1 9 (100%) 18.4±12.0 0 3 (37.5%)
CCTGA 8 6 (75.0%) 31.6±12.6 1 (12.5%) 45.0 2 (25.0%) 0
DORV 5 1 (20.0%) 23.4±3.0 5 (100%) 6.2±4.6 0 0
PA 3 0 22.3±1.2 2 (66.7%) 4.5±0.7 0 0
CCA 2 0 22.0±2.8 2 (100%) 4.5±0.7 0 0
BWG 1 0 28.0 1 (100%) 4.0 0 0
Total 418 208 (49.9%) 30.0±10.5 322 (77.0%) 9.5±8.1 75 (17.9%) 96 (23.0%)
*patients with normal pulmonary pressure; ASD — atrial septal defect type secundum and sinus venosus, VSD — ventricular septal defect,
PDA — persistent ductus arteriosus, BAV — bicuspid aortic valve, PS — pulmonary stenosis, PPVC — partial pulmonary venous connection,
Marfan — Marfan syndrome, IPD — idiopathic pulmonary dilatation, MI — mitral insufficiency, Williams — Williams syndrome, CoAo — coarctation
of aorta, ToF — tetralogy of Fallot, ASD I — primum atrial septal defect, CAVC — common atrio-ventricular canal, Eisenmenger — Eisenmenger syndrome,
SubvalvAS — subvalvular aortic stenosis, Ebstein — Ebstein anomaly, DTGA — transposition of great arteries, CCTGA — congenitally corrected
transposition of the great arteries, DORV — double outlet right ventricle, PA — pulmonary atresia, CCA — congenital coronary anomalies, BWG — Bland-
-White’a-Garland syndrome
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population. FA/FLA was diagnosed in 48 patients,
3.7% of the total, SVT in 85 patients, 6.6%. Tables
2 and 3 present the incidence of the analyzed
arrhythmia for particular simple and complex CHD.
Patients diagnosed with SVA were older than
those without this arrhythmia: 37.3 ± 14.5 years vs.
28.6 ± 9.8 years (p = 0.0001). SVA incidence was
greater in patients with complex lesions: 43 (4.9%)
vs. 90 (21.5%); p = 0.00001, in patients without past
cardiac surgery: 76 (8.2%) vs. 57 (16.7%); p =
= 0.00001, in patients with cyanosis: 36 (31.0%) vs.
97 (7.9%); p = 0.00001, and with baseline impair-
ment of heart function (NYHA > I): 52 (47.8%) vs.
81 (6.8%); p = 0.00001, as compared with patients
without the above clinical signs. There were no
differences between males and females with respect
to SVA incidence: 63 (10.7) vs. 70 (9.7%); p = 0.43.
Ten-year follow-up revealed that the likelihood of
SVA for the whole studied population was after two
years 5.2%, after five years 13.7% and after ten
years 14.4% (Fig. 1). Univariate analysis proved that
the probability of SVA in adults with CHD was also
greater in patients with complex lesions (p = 0.00001),
without a history of cardiac surgery (p = 0.0001),
with baseline impairment of heart function (NYHA
> I) (p = 0.0001) and cyanosis (p = 0.0001), as
compared to patients without the above clinical signs.
Gender does not seem to have much significance
(p = 0.32; Fig. 2–6). Cox regression analysis
showed that heart function impairment (NYHA > I)
is the strongest independent risk factor for SVA
(HR = 4.66). Congenital heart disease complexity
(HR = 2.31) and patients’ age are also significant pro-
gnostic factors for this arrhythmia (HR = 1.32). No
prognostic strength was associated with past cardiac
surgery, cyanosis presence or gender (Table 4).
Discussion
SVA were present in 10.3% of the observed
adults with CHD. The likelihood of their occurrence
equaled 5.2% after two years, 13.7% after five years
and 14.4% after ten years. According to Jane
Somerville, SVA is the most frequent clinical pro-
blem in that population. It occurred in 23% of her
treated patients [1], a significantly higher rate than
observed in our group. This is probably explained
by in the higher number of patients with complex
heart defects attending Royal Brompton Hospital
presenting with this arrhythmia more frequently.
Our study pointed out the congenital heart
defect complexity as an independent risk factor for
SVA. It is also known that patients with complex
CHD more often require surgery, as surgicalTa
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Table 3. Incidence of supraventricular arrhythmia in patients with complex congenital heart disease. Percentage of patients in the individual congeni-
tal heart disease subgroups.
Total CoAo ToF ASD I CAVC Eisen- Supvalv Single Ebstein DTGA Valve CCTGA DORV Pulmonary CCA BWG
menger  AS  ventricle conduits atresia
Number 418 106 101 38 32 27 24 23 20 19 9 8 5 3 2 1
of subjects
FA+FLA 34 2 3 2 0 7 1 12 2 2 0 2 1 0 0 0
(%)  (8.1%)  (1.9%)  (2.9%)  (5.2%)  (25.9%)  (4.1%)  (52.1%)  (10.0%)  (10.5%)  (25.0%) (20.0%)
SVT 56 7 11 4 3 7 1 4 6 9 0 2 2 1 0 0
(%) (13.4%)  (6.6%)  (10.8%)  (10.5%)  (9.3%)  (25.9%)  (4.1%)  (17.4%)  (33.3%)  (47.3%)  (25%) (40.0%) (33.3%)
FA+FLA+ 90 9 14 6 3 14 2 16 8 11 0 4 3 0 0 0
+SVT (%)  (21.3%)  (8.4%)  (13.9%)  (15.7%)  (9.3%)  (51.8%)  (8.2%)  (69.6%)  (40.0%)  (57.9%)  (50.0%) (60.0%)
FA+FLA — atrial fibrillation + flutter, SVT — supraventricular tachycardia. Abbreviations as in Table 1
223
Olga Trojnarska et al., Risk factors of SVA in adults with CHD
www.cardiologyjournal.org
correction allows most to reach adulthood. Howe-
ver, the analysis performed showed that despite the
reduced probability of SVA following surgical
correction it does not predict the risk of this arrhy-
thmia. Cardiac surgery improves hemodynamic
parameters in the first place, yet postoperative
scarring can turn out to be an additional arrhythmo-
genic factor and also lead to electrical remodeling.
Therefore, adults with complex CHD visiting the
outpatient clinic for the first time require particu-
lar monitoring for analyzed arrhythmia, regardless
of their history of cardiac surgery.
Among adults with complex defects, SVA oc-
curred most frequently in patients with functionally
single ventricle. Significantly altered anatomy and
Fontan operation led to increased pressure and
dilation of the right atrium, as well as so-called ‘inci-
sional tachycardia’ [9, 11, 12]. The analyzed arrhy-
thmia in the transposition of the great arteries
(DTGA), resulting from increased atrial pressure
and presence of post-operative scarring in its wall
after Senning/Mustard procedure, occurs in 35% to
50% of cases after 15 years of follow-up [13, 14].
Long-term observation of patients with DTGA after
atrial correction was published by Moons et al. [10],
who reported that after 20 years 43% of patients
presented with SVA and 65% of them after 25 years.
However, other authors say that ten years after
surgery, sinus rhythm was retained in 95–98% of
these patients [15]. In adults with congenitally
corrected transposition of great arteries (CCTGA),
discussed arrhythmia is associated with altered
conducting fibers pathways observed in 2% to 4%
of that group of patients and, resulting from tricu-
spid insufficiency, left atrial enlargement leading to
electrical inhomogeneity [16–18].
The available literature states that patients
operated for tetralogy of Fallot (ToF) present with
SVA in 2% to 34% of cases [7, 19, 20]. This signifi-
Figure 6. Estimated survival free from supraventricular
arrhythmias (SVA) with respect to NYHA functional
class in the entire study group.
Figure 4. Estimated survival free from supraventricular
arrhythmias (SVA) in operated and un-operated patients
with congenital heart disease.
Figure 5. Estimated survival free from supraventricular
arrhythmias (SVA) in cyanotic and acyanotic patients
with congenital heart disease.
Table 4. Predictors of supraventricular arrhythmia
in univariate and multivariate analysis.
Variable P HR 95% CI
NYHA > I 0.001 4.66 2.67–8.80
Complex CHD 0.0007 2.31 1.40–3.31
Age 0.0002 1.31 1.14–1.53
(10-year
intervals)
Male sex 0.67 1.07 0.74–1.65
Cyanosis 0.45 0.77 0.42–1.47
Cardiac surgery 0.35 0.74 0.72–1.56
HR — hazard ratio; CI — confidence interval; CHD — congenital heart
disease
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cant discrepancy of data may be due to the fact that
most patients with this anatomical defect have
right bundle branch block, leading to diagnostic pro-
blems differentiating between supraventricular and
ventricular arrhythmias [1]. In that group of pa-
tients, SVA is associated with increased pressure
in the right atrium, secondary to elevated end-
-systolic pressure in the right ventricle resulting
from postoperative pulmonary insufficiency [7, 8, 21].
Pulmonary regurgitation is usually the result of
transannular patch use, which was applied to 92%
of observed patients. Our population included only
seven adults with ToF who had not undergone past
surgical correction of this defect; one such person
presented with persistent atrial fibrillation. The
scope of surgical intervention affects the rate of
SVA occurrence in patients with double outlet right
ventricle [22]. In Ebstein’s anomaly, the substrate
for SVA, observed in 25–40% of those patients is the
right atrium, enlarged by the atrialysed part of the
right ventricle as well as fetal atrioventricular addi-
tional conducting pathways seen in 5–25% of them
[4, 8, 23].
In patients with partial and common atrioven-
tricular canal (ASDI and CAVC) this arrhythmia is
enhanced by additional anatomical substrate of
endocardial cushion defects [6, 24]. Subjects with
different forms of common atrioventricular canal are
also prone to analyzed arrhythmia due to scar for-
mation after closure of septal defect and reconstruc-
tion of atrioventricular valves usually leaving signi-
ficant mitral regurgitation [6, 12, 25]. Probably
because of this, SVA was observed more often in the
subgroup of patients with atrial septal defect (ASD)
primum than in subjects with secundum atrial
septal defect. Doubts about the impact of atrial septal
defect closure in the adult population are far from
being dispelled. Most researchers state that this
arrhythmia incidence does not decrease after cardiac
surgery but it can be more responsive to pharma-
cotherapy [26, 27]. Our observations showed that
analyzed arrhythmia occurred more often in uno-
perated patients (16.6% vs. 4.0%), in keeping with
the findings of other investigators [28, 29].
The performed analysis showed that impaired
cardiac function (NYHA > I) observed during the
first visit was the strongest independent risk fac-
tor for supraventricular arrhythmias in long term
follow-up. The relationship between this arrhythmia
and heart failure has been confirmed by other
authors. SVA, observed in about 70% of our patients
with hearts of the single ventricle physiology is
associated with its functional impairment and se-
condly with increased atrial pressure and, in con-
sequence, atrial remodeling [11, 30]. Fontan repair
delays, but does not prevent, hemodynamic dete-
rioration which leads to increased incidence of
discussed arrhythmia, appearing in 11% to 57% of
those patients after 15 years of observation [11, 30,
31]. Supraventricular arrhythmias occurred in more
than half of adults with Eisenmenger syndrome,
usually presenting functional impairment [32].
Heart failure in this group of patients results from
intracardiac shunts and growing tricuspid insuffi-
ciency leading to volume overload as well as right
ventricular pressure overload due to increased pul-
monary pressure [33, 34]. SVA is likely to be the
result of right atrial volume overload, dilatation of
its wall leading to ‘electrical remodeling’ [6, 26].
SVAs at the same time as impairment of cardiac
function is also seen in patients with DTGA [14, 35, 36].
According to Harrison et al. [20], in patients after
ToF total correction, the risk of SVA incidence
is associated with a palliative shunt, which facilitates
left ventricle failure, and also with pulmonary
regurgitation, resulting in right ventricle failure [7].
It has been proved that impairment of cardiac func-
tion is a significant contributor of SVA in patients
with Ebstein’s anomaly [37]. In adults with CCTGA
the incidence of analyzed arrhythmia increases with
the worsening of tricuspid regurgitation, influencing
the function of the systemic ventricle [16, 18].
In patients after ASDI correction, a similar relation-
ship exists between mitral regurgitation and left
ventricle function [24, 25]. Among those with
complex defects, SVAs appeared least frequently in
patients with coarctation of the aorta, in whom they
are likely the result of functional impairment due
to hypertension and coronary heart disease [8, 38].
In the subgroup of simple defects, analyzed arrhy-
thmia occurred mostly in patients with ASD. Age-
related left-right shunt due to decreased left ven-
tricle compliance and increased systemic pressure
can lead to mitral regurgitation and a gradual dete-
rioration of cardiac function. On the other hand, SVA
enhances left-right shunt, which further impairs
cardiac function [27, 28]. In adults with ventricular
septal defect this arrhythmia occurs less frequently,
usually in those who underwent cardiac surgery
later in life, which entails functional impairment due
to chronic left-right shunt [39, 40].
The ten-year observation of adults with con-
genital heart disease showed that the risk of SVA
in all studied groups was higher in patients with cy-
anosis. Desaturation is always the result of serious
anatomical and hemodynamic changes. According
to Perloff et al. [41], it leads to significant myocar-
dial changes, similar to chronic ischemia. However,
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Cox regression analysis did not yield any prognostic
value of this clinical feature. It can be explained
by the fact that the majority (92%) of patients with
cyanosis and SVAs presented with heart failure
and also 89% of cyanotic patients represented com-
plex anomalies. Statistical impact of desaturation
was weaker in this analysis and eclipsed by both
above-mentioned factors. Except for a single report
pertaining to Ebstein’s anomaly, which confirmed
the role of cyanosis as one of the risk factors of SVA,
there is no known data documenting such a direct
relationship [37].
Regression analysis showed that patient age is
a significant risk factor for SVA. The results were
undoubtedly influenced by the advanced age of the
population presenting with this arrhythmia, the
large group of patients with ASD and the age of the
oldest subgroup of patients with Ebstein’s anomaly
who also frequently presented with SVA. Literature
data confirms that the incidence of this arrhythmia
in patients with ASD and ventricular septal defect
increases with age [28, 39, 40]. Other authors also
claim that age is a risk factor for SVA in some
complex defects, which has been documented in patients
with previous Mustard [42], Fontan operation [43],
with CCTGA [17] and after ToF correction [7, 20].
The sex of studied patients had no prognostic
value in analyzed arrhythmia. The available litera-
ture also does not confirm any such relationship.
Conclusions
1. The initial impairment of heart function, con-
genital heart defect complexity and the pa-
tient’s age, all increase the risk of supraven-
tricular arrhythmia in adults with congenital
heart disease.
2. Cyanosis and the lack of a past cardiac opera-
tion lead to higher incidence of the analyzed
arrhythmia, but are not risk factors for its
occurrence.
3. A patient’s gender has no prognostic significan-
ce for supraventricular arrhythmias.
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